Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

FI-700

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Fms-like tyrosine kinase-3 (FLT3) inhibitors have been used to overcome the dismal prognosis of acute myeloid leukemia (AML) with… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2011
2011
Internal tandem duplication of FMS‐like receptor tyrosine kinase 3 (FLT3/ITD) within its juxtamembrane domain is a frequent… Expand
2010
2010
Treatment using Fms-like tyrosine kinase-3 (FLT3) inhibitors is a promising approach to overcome the dismal prognosis of acute… Expand
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • figure 6
2009
2009
Abstract 3108 Poster Board III-45 Background FLT3 (FMS-like receptor tyrosine kinase 3) is a member of the class III receptor… Expand
2007
2007
Purpose: The aim of this study was to evaluate the antileukemia activity of a novel FLT3 kinase inhibitor, FI-700. Experimental… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3